China Traditional Chinese Medicine Holdings Co. Limited announced that every agenda item at the 26 June 2026 annual general meeting was approved by poll, reflecting solid shareholder backing for the current strategic and governance framework.
A total of 5.04 billion shares were in issue and entitled to vote; 2.68 billion votes were cast on each resolution. Computershare Hong Kong Investor Services Limited acted as scrutineer. No shareholders were required to abstain, and none exercised a right to attend but withhold voting.
Key voting outcomes:
• Financial statements for the year ended 31 December 2025 received 99.46 % support (2.67 billion votes in favour).
• Six directors were re-elected with approval levels ranging from 95.80 % to 99.35 %. The lowest level of support (95.80 %) was recorded for Mr. CHEN Kun, while Mr. LI Weidong received the highest (99.27 %).
• Directors’ remuneration authority passed with 99.55 % backing (2.67 billion votes).
• BDO Limited was re-appointed as external auditor with 94.73 % support (2.54 billion votes).
All resolutions met the simple-majority threshold, reinforcing board continuity. The meeting was attended—physically or electronically—by the full slate of executive, non-executive and independent non-executive directors, underscoring the company’s commitment to governance transparency.
Comments